4-ipomeanol has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohr, L; Mohr, UG; Rainov, NG; Wands, JR | 1 |
| Donehower, RC; Lakhanpal, S; Rowinsky, EK | 1 |
| Czerwinski, M; Gelboin, HV; Gonzalez, FJ; Korzekwa, K; McLemore, TL; Nhamburo, PT; Philpot, RM | 1 |
1 trial(s) available for 4-ipomeanol and Cancer of Liver
| Article | Year |
|---|---|
Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Terpenes; Treatment Outcome | 2001 |
2 other study(ies) available for 4-ipomeanol and Cancer of Liver
| Article | Year |
|---|---|
Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation; Genetic Therapy; Green Fluorescent Proteins; Humans; Immunoblotting; Liver Neoplasms; Luminescent Proteins; Pharmacogenetics; Prodrugs; Rabbits; Terpenes; Tumor Cells, Cultured | 2000 |
Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism.
Topics: Biotransformation; Carcinoma, Hepatocellular; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA; Humans; Liver Neoplasms; Species Specificity; Terpenes; Toxins, Biological; Vaccinia virus | 1991 |